g PG, Fox KA, Shao M, et al.
Bleeding complications with dual antiplatelet therapy among patients
with stable vascular disease or risk factors for vascular disease: results
from the Clopidogrel for High Atherothrombotic Risk and Ischemic
Stabilization, Management, and Avoidance (CHARISMA) trial. Circulation 2010;121:2575-83.
85. EfÔ¨Å